Stay updated on Daratumumab Efficacy in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Efficacy in Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab Efficacy in Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded Revision: v3.4.2 and removed prior notices including Revision: v3.4.1 and the funding-status message; this change affects only site metadata and does not modify study details or user-facing content.SummaryDifference0.5%

- Check15 days agoChange DetectedA site-wide funding-lapse notice and NIH operating status update were added to the page. The revision tag changed from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check22 days agoChange DetectedThe changes include a glossary toggle label, capitalization updates for QC-related metadata ('Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new 'Revision: v3.4.0' entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check36 days agoChange DetectedThe only change is a minor revision update from v3.3.3 to v3.3.4; there are no user-facing content or functionality changes to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded a dedicated Locations section showing an Ohio site; removed the prior Ohio Locations entry and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check86 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 in the page header. The rest of the study details and layout appear unchanged.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Efficacy in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Efficacy in Multiple Myeloma Clinical Trial page.